Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening
- PMID: 28030379
- DOI: 10.1097/MOL.0000000000000388
Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening
Abstract
Purpose of review: In this review, how genetic testing has provided major new insights regarding the population burden of familial hypercholesterolemia (FH) are reviewed. In addition, the role of genetic testing in cascade screening for FH and an updated MEDPED (Make Early Diagnoses to Prevent Early Death in MEDical PEDigrees) algorithm for the clinical diagnosis of FH are presented.
Recent findings: For the first time, recent application of genetic testing for FH in large populations has provided firm estimates of the prevalence of FH (at least one in 220) in the USA. High associated risks of coronary artery disease make FH the most common genetic cause of premature coronary artery disease.
Summary: Genetic testing has yielded accurate, new estimates of the population burden of FH. The potential benefits of early diagnosis of FH on a population-wide level have not yet begun to be realized.
Similar articles
-
Familial hypercholesterolemia in the Czech Republic: more than 17 years of systematic screening within the MedPed project.Physiol Res. 2017 Apr 5;66(Suppl 1):S1-S9. doi: 10.33549/physiolres.933600. Physiol Res. 2017. PMID: 28379025 Review.
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
-
Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.Curr Opin Lipidol. 2017 Apr;28(2):144-151. doi: 10.1097/MOL.0000000000000397. Curr Opin Lipidol. 2017. PMID: 28157722 Review.
-
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.Am Heart J. 2014 Mar;167(3):342-349.e17. doi: 10.1016/j.ahj.2013.12.008. Epub 2013 Dec 21. Am Heart J. 2014. PMID: 24576518
-
Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia.Genet Med. 2019 May;21(5):1173-1180. doi: 10.1038/s41436-018-0311-2. Epub 2018 Oct 1. Genet Med. 2019. PMID: 30270359 Free PMC article.
Cited by
-
Strategic vision for improving human health at The Forefront of Genomics.Nature. 2020 Oct;586(7831):683-692. doi: 10.1038/s41586-020-2817-4. Epub 2020 Oct 28. Nature. 2020. PMID: 33116284 Free PMC article. Review.
-
Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry.J Clin Med. 2020 Oct 29;9(11):3489. doi: 10.3390/jcm9113489. J Clin Med. 2020. PMID: 33137929 Free PMC article.
-
Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab.Biomedicines. 2022 Dec 16;10(12):3273. doi: 10.3390/biomedicines10123273. Biomedicines. 2022. PMID: 36552028 Free PMC article. Review.
-
Putting Into Perspective the Hazards of Untreated Familial Hypercholesterolemia.J Am Heart Assoc. 2017 Jun 26;6(6):e006553. doi: 10.1161/JAHA.117.006553. J Am Heart Assoc. 2017. PMID: 28652387 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
